Clinical Trial Update: A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating blinatumomab in combination with chemotherapy for newly diagnosed B lymphoblastic leukemia; the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-lymphoblastic Lymphoma
• Down Syndrome
• Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (Blincyto) (blinatumomab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING